aTyr Pharma, Inc. (ATYR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 190K | 0 | 0 | 0 | 0 | 0 | 235K | 0 | 353K | 0 |
| Revenue Growth % | - | - | - | - | -100% | - | -100% | - | - | -100% | - | - |
| Cost of Goods Sold | 394K | 0 | 22.13M | 0 | 0 | 12.23M | 0 | 0 | 0 | 407K | 993K | 586K |
| COGS % of Revenue | - | - | 11647.37% | - | - | - | - | - | - | - | 281.3% | - |
| Gross Profit | -394K | 0 | -21.94M | 0 | 0 | -12.23M | 0 | 0 | 235K | -407K | -640K | -586K |
| Gross Margin % | - | - | -11547.37% | - | - | - | - | - | 100% | - | -181.3% | - |
| Gross Profit Growth % | - | 100% | - | - | -100% | -2904.42% | 100% | 100% | 131.13% | -104.2% | -54.59% | - |
| Operating Expenses | 11.04M | 14.8M | 4.8M | 20.31M | 15.77M | 3.59M | 18.14M | 17.32M | 16.87M | 15.55M | 11.97M | 12.97M |
| OpEx % of Revenue | - | - | 2528.95% | - | - | - | - | - | 7179.15% | - | 3392.35% | - |
| Selling, General & Admin | 4.12M | 3.9M | 4.8M | 4.93M | 3.96M | 3.59M | 3.34M | 3.34M | 3.51M | 2.8M | 1.66M | 3.13M |
| SG&A % of Revenue | - | - | 2528.95% | - | - | - | - | - | 1492.34% | - | 469.12% | - |
| Research & Development | 7.32M | 10.89M | 22.13M | 15.38M | 11.81M | 12.23M | 14.81M | 13.97M | 13.36M | 12.76M | 10.32M | 9.84M |
| R&D % of Revenue | - | - | 11647.37% | - | - | - | - | - | 5686.81% | - | 2923.23% | - |
| Other Operating Expenses | -394K | 0 | -1000K | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.44M | -14.8M | -26.75M | -20.31M | -15.77M | -15.82M | -18.14M | -17.32M | -16.64M | -15.96M | -12.62M | -13.56M |
| Operating Margin % | - | - | -14076.32% | - | - | - | - | - | -7079.15% | - | -3573.65% | - |
| Operating Income Growth % | 27.5% | 6.47% | -47.41% | -17.31% | 5.19% | 0.87% | -43.82% | -27.71% | -30.1% | -100.74% | 6.5% | -7.74% |
| EBITDA | -11.04M | -14.4M | -26.58M | -19.93M | -15.39M | -15.64M | -17.75M | -16.93M | -15.87M | -15.55M | -11.62M | -12.97M |
| EBITDA Margin % | - | - | -13989.47% | - | - | - | - | - | -6751.49% | - | -3292.35% | - |
| EBITDA Growth % | 28.25% | 7.95% | -49.7% | -17.68% | 3% | -0.6% | -52.77% | -30.53% | -31.86% | -114.42% | 11.13% | -5.48% |
| D&A (Non-Cash Add-back) | 394K | 394K | 165K | 387K | 383K | 175K | 388K | 383K | 770K | 407K | 993K | 586K |
| EBIT | -11.44M | -14.8M | -25.75M | -20.31M | -15.77M | -15.82M | -18.14M | -17.32M | -16.64M | -15.96M | -12.62M | -13.56M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 645K | 832K | 999K | 781K | 892K | 852K | 882K | 1.01M | 1.15M | 1.2M | 1.27M | 1.22M |
| Pretax Income | -10.79M | -13.96M | -25.75M | -19.53M | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M | -12.34M |
| Pretax Margin % | - | - | -13550.53% | - | - | - | - | - | -6590.21% | - | -3213.03% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -10.79M | -13.96M | -25.74M | -19.53M | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M | -12.34M |
| Net Margin % | - | - | -13549.47% | - | - | - | - | - | -6591.91% | - | -3212.46% | - |
| Net Income Growth % | 27.48% | 6.71% | -49.16% | -19.78% | 3.94% | -1.4% | -52.2% | -32.16% | -29.62% | -96.25% | 14.38% | 0.66% |
| Net Income (Continuing) | -10.79M | -13.96M | -25.75M | -19.53M | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M | -12.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -193K | -192K | -191K | -189K | -188K | -187K | -186K | -184K | -184K | -188K | -187K | -185K |
| EPS (Diluted) | -0.11 | -0.14 | -0.26 | -0.22 | -0.17 | -0.18 | -0.23 | -0.23 | -0.23 | -0.25 | -0.20 | -0.22 |
| EPS Growth % | 35.29% | 22.22% | -13.04% | 4.35% | 26.09% | 28% | -15% | -4.55% | 20.69% | 3.85% | 56.52% | 50% |
| EPS (Basic) | -0.11 | -0.14 | -0.26 | -0.22 | -0.17 | -0.18 | -0.23 | -0.23 | -0.23 | -0.25 | -0.20 | -0.22 |
| Diluted Shares Outstanding | 98.04M | 98.01M | 97.15M | 90.12M | 86.49M | 82.72M | 75.8M | 72.28M | 66.08M | 59.26M | 57.89M | 55.14M |
| Basic Shares Outstanding | 98.04M | 98.01M | 97.15M | 90.12M | 86.49M | 82.72M | 75.8M | 72.28M | 66.08M | 59.26M | 57.89M | 55.14M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |